Xu, Zangwei
29  results:
Search for persons X
?
1

Discovery of MK-1084: An Orally Bioavailable and Low-Dose K..:

Ma, Xiaoshen ; Sloman, David L. ; Duggal, Ruchia...
Journal of Medicinal Chemistry.  67 (2024)  13 - p. 11024-11052 , 2024
 
?
2

Identification of Potent Reverse Indazole Inhibitors for HP..:

Yu, Elsie C. ; Methot, Joey L. ; Fradera, Xavier...
ACS Medicinal Chemistry Letters.  12 (2021)  3 - p. 459-466 , 2021
 
?
 
?
7

Potent, non-covalent reversible BTK inhibitors with 8-amino..:

Liu, Jian ; Guiadeen, Deodial ; Krikorian, Arto...
Bioorganic & Medicinal Chemistry Letters.  30 (2020)  17 - p. 127390 , 2020
 
?
8

Discovery of novel BTK inhibitors with carboxylic acids:

Gao, Xiaolei ; Wang, James ; Liu, Jian...
Bioorganic & Medicinal Chemistry Letters.  27 (2017)  6 - p. 1471-1477 , 2017
 
?
9

Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhi..:

Boga, Sobhana Babu ; Alhassan, Abdul-Basit ; Liu, Jian...
Bioorganic & Medicinal Chemistry Letters.  27 (2017)  16 - p. 3939-3943 , 2017
 
?
11

Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible ..:

Liu, Jian ; Guiadeen, Deodial ; Krikorian, Arto...
ACS Medicinal Chemistry Letters.  7 (2015)  2 - p. 198-203 , 2015
 
?
14

Discovery of PDK1 Kinase Inhibitors with a Novel Mechanism ..:

Bobkova, Ekaterina V. ; Weber, Michael J. ; Xu, Zangwei...
Journal of Biological Chemistry.  285 (2010)  24 - p. 18838-18846 , 2010
 
1-15